Plano, TXNCT05966467Now EnrollingIRB Ready

Neuromyelitis Optica Spectrum Disorder Clinical Trial in Plano, TX

Access cutting-edge neuromyelitis optica spectrum disorder treatment through this clinical trial at a research site in Plano. Study-provided care at no cost to qualified participants.

Sponsored by Alexion Pharmaceuticals, Inc.

Quick Self-Assessment

See if you qualify for this Plano location

Preparing your pre-screening questions…

Expert Care in Plano

Access neuromyelitis optica spectrum disorder specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related neuromyelitis optica spectrum disorder treatment provided free

Apply for This Plano Location

Check if you qualify for this neuromyelitis optica spectrum disorder clinical trial in Plano, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Plano

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Plano site if eligible
  4. 4Begin participation

About This Neuromyelitis Optica Spectrum Disorder Study in Plano

Long-term, multicenter, multinational, observational, registry of patients with AQP4+ NMOSD that is designed to collect data on clinical outcomes and safety in patients prescribed Alexion C5 inhibitor therapies (C5IT). The registry will also collect data on patient reported outcomes (PROs), quality of life (QoL), and targeted AQP4+ NMOSD therapies used to provide evidence on the real-world impact of ALXN-C5IT on patients with AQP4+ NMOSD.

Sponsor: Alexion Pharmaceuticals, Inc.

Who Can Participate

Inclusion Criteria

Participant is ≥ 18 years of age at the time of enrollment in the Registry.
Participant must have a confirmed diagnosis of AQP4+ NMOSD.
At the time of enrollment in the Registry, participants must be receiving treatment with ALXN-C5IT for the purpose of chronic relapse prevention in a manner consistent with the local label. Specifically, they should have received at least 1 dose of eculizumab within 4 weeks prior to enrollment or at least 1 dose of ravulizumab within 12 weeks prior to enrollment.
Participants must have both the following historical data available to be enrolled in the Registry: ALXN-C5IT dosing information since initiation and number and types of relapses from 1 year prior to ALXN-C5IT initiation through Registry enrollment.

Exclusion Criteria

Participants currently enrolled in an interventional clinical study for the treatment of AQP4+ NMOSD in which the intervention is a drug.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Plano?

Yes, this clinical trial (NCT05966467) has an active research site in Plano, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Neuromyelitis Optica Spectrum Disorder Treatment Options in Plano, TX

If you're searching for neuromyelitis optica spectrum disorder treatment options in Plano, TX, this clinical trial (NCT05966467) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Plano research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neuromyelitis optica spectrum disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all neuromyelitis optica spectrum disorder clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Plano, TX

See all pulmonary embolism clinical trials recruiting in Plano — not just this study.

Browse Pulmonary Embolism Trials in Plano

Ready to Join in Plano?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Plano, TX